RE:RE:RE:RE:RE:RE:RE:RE:I see the PPS heading over $2......poc, The point of my post was NASDAQ listing can provide great SP results. Perhaps not essential for RVX but would be better to have the best SP possible when it comes to the least dilutive path to fully funding ph 3. I'm sure you understand this. Yes Trillium did come from the ashes of SSS, I'm sure a sharp guy like you understands tax pools etc. SSS I believe was in stem cell treatments for brain trauma while Trillium holds great promise in the immuno-oncolgy space. Very different fields, very different companys. Much more than a "rename". To me a "smart biotech investor" would have stepped into the ashes when David Allan did (YM biosciences amongst other successes), traded this a few times and now be holding free shares. Glad you had a good laugh, I'm laughing too, all the way to the bank.